Bank of New York Mellon »

Seres Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $255k 329k 0.77
2023-12-31 $482k 344k 1.40
2023-09-30 $763k 321k 2.38
2023-06-30 $1.5M 323k 4.79
2023-03-31 $1.4M 251k 5.67
2022-12-31 $1.4M 249k 5.60
2022-09-30 $2.1M 247k 8.47
2022-06-30 $730k 213k 3.43
2022-03-31 $1.6M 226k 7.11
2021-12-31 $1.9M 221k 8.47
2021-09-30 $1.9M 274k 6.96
2021-06-30 $6.2M 261k 23.85
2021-03-31 $4.3M 207k 20.59
2020-12-31 $5.3M 218k 24.49
2020-09-30 $5.3M 188k 28.31
2020-06-30 $0 133k 0.00
2020-03-31 $413k 115k 3.60
2019-12-31 $387k 112k 3.45
2019-09-30 $365k 91k 4.01
2019-06-30 $204k 64k 3.19
2019-03-31 $611k 89k 6.88
2018-12-31 $386k 85k 4.52
2018-09-30 $601k 79k 7.58
2018-06-30 $683k 79k 8.61
2018-03-31 $682k 93k 7.33
2017-12-31 $841k 83k 10.13
2017-06-30 $910k 81k 11.30
2017-03-31 $923k 82k 11.28
2016-12-31 $812k 82k 9.91
2016-09-30 $826k 68k 12.25
2016-06-30 $1.7M 57k 29.05